CorDx’s Post

"Introducing our cutting-edge Blood Gas and Electrolyte Machine, meticulously crafted to deliver unparalleled accuracy and efficiency in diagnosing critical patient conditions. With SureBio Diagnostics Pakistan, rest assured of swift, precise, and reliable results, empowering healthcare professionals to make informed decisions swiftly. Our state-of-the-art technology ensures seamless integration into your healthcare facility, enhancing workflow and patient care. Trust SureBio for innovative solutions that prioritize patient well-being and clinical excellence. #SureBio #InnovativeHealthcare #PatientWellness"

👩⚕️ Dive deeper into the world of healthcare solutions with CAPED Medical! 💼 Explore our comprehensive range of products and services designed to elevate patient care and streamline medical processes. From cutting-edge diagnostics to innovative treatment options, we've got you covered. Visit our website today to discover the future of healthcare. #HealthcareSolutions #Innovation #CAPEDMedical 🌐🏥

Asembia is hopping. Meetings are appropriately fueled by bread and chocolate - you know the staff of life! Some hot takes from the field: 1. Top topic for discussion: Cordavis' success with Humira biosimilars as evidence that a big PBM has figured out a business model that works for the post-rebate era. 2. Disruptors vs vertical integrators: When it comes to CVS's Cordavis, it's probably too soon to say "mission accomplished". Real Endpoints Ryan Walsh notes the move further solidifies the advantages of vertical integration, which begs the question where, how, and when will disruptors drive change in the drug value chain. 3. Right-sizing market access: A perennial topic whenever market access peeps gather. This year lots of chatter about size and scale, with a focus on what capabilities are really needed to ensure patient access and profitable coverage for innovations. Is this a sign of a strategic shift? 🤔 We can but hope. 4. 340B angst: Jeff Berkowitz notes when it comes to 340B pricing, "consternation" is the word of the day. Given the perverse incentives at work around 340B that's ... er ... putting it nicely. If you have questions or want to chat about market access strategy, pricing and contracting, or patient support, Jeff Berkowitz, Susan Raiola, Ryan Walsh, Rob O'Brien, and Jeff Parish are on the ground at #asx2024. Dance cards are full but not completely packed, so reach out.

QuickMIC®, currently the most rapid AST system on the market, is now available in the UK and Ireland! 🦠 Gradientech is thrilled to announce an exclusive distribution agreement with AB Scientific for the commercialisation of the QuickMIC system in the United Kingdom and Ireland.   🗣️“AB Scientific are at the forefront of improving diagnostics in the UK and Ireland with innovative and high-quality products, and the addition of the QuickMIC system supports our mission. We have been focused on improvements to the Sepsis Pathway for several years and by introducing the QuickMIC technology to the UK and Irish market we enable even faster turnaround times, reduced healthcare costs, and ultimately more saved lives. Our customers are at the forefront of everything they do, and the QuickMIC solution will allow them to make a real difference to their patients’ lives”, comments Greg Dobson, Director at AB Scientific. The exciting news (link in the comments) was also shared by 360Dx, an independent online news organization that tracks the biggest players in the diagnostics market and reports on regulatory, reimbursement, and policy issues that impact the commercial operations of clinical labs. #distribution #healthcare #Europe #AST #medicaldevices 

Facilitate safe, manageable scale-up with OCELLOS by TrakCel. 📈 Easily add: 🔹 Patients, healthcare sites, CMOs & logistics partners. 🏥 🔹 Countries, languages and time zones. 🌎 🔹 Therapies and patient indications. 🧬 Find out more: https://loom.ly/bnRL-X0 #CGT #CellandGene #CellTherapy #GeneTherapy #AdvancedTherapies

Check out this insightful video featuring Mr. Pravin Ahir, Accounts Department- Beacon Group! 🌟 Discover the expertise of Mr. Pravin Ahir, who has been in the IVD industry for a long time. Don’t miss out on his valuable insights on his remarkable journey and contributions to diagnostic advancements. 🏥✨ #IVDIndustry #BeaconGroup #Innovation #Healthcare #Expertise #DiagnosticAdvancements #beacon #BeaconDiagnostics

Check out this insightful video featuring Mr. Nilesh Patel, Commercial Department- Beacon Group! 🌟 Discover the expertise of Mr Nilesh, who is in the IVD industry for over 11 years. Don’t miss out on his valuable insights on his remarkable journey and contributions to diagnostic advancements. 🏥✨ #IVDIndustry #BeaconGroup #Innovation #Healthcare #Expertise #DiagnosticAdvancements #beacon #BeaconGroup

YourBio Health (formerly known as Seventh Sense Biosystems), was founded in 2008 in MedFord MA under steering of the venture capital organization Flagship Pioneering. The focus of the company has always been to make blood collection accessible to all and most importantly make it as pain-free as possible. TAP® blood collection devices feature innovative Halo ™ technology that enables a lay-person at home (or any setting) to painlessly collect a whole blood sample of 500 microlitres or more without the need for a trained phlebotomist, presenting a whole wealth of application opportunities in any healthcare setting. The first generation of the TAP device was launched in 2018 with an initial FDA clearance for HbA1c. The second generation of the device, TAP II was launched in 2019 and received a wide CE Mark approval as a Class II device for at-home blood collection. 2023 saw the CE Mark approval of TAP Micro Select which extended the breadth of applications possible with the blood sample collected as this device is compatible with Becton Dickinson Microtainer® sample collection tubes. YourBio Health have also established partnerships with labs in the UK and EU and are able to offer a full ‘end-end’ solution for at-home ‘order-test-report’, our team are also able to facilitate API across specifics elements of the workflow as necessary to support your desired client journey. Meet them at #GIANT2023 on 4-5 December. #digitalhealth #healthcare #healthtech #innovation

🔍 Looking Ahead: The integration of Continuous Glucose Monitoring (CGM) technology could be the next milestone in our journey. Imagine a world where healthcare providers have access to even more comprehensive, real-time data to inform patient care. This isn't just about progress; it's about transforming lives. Let's innovate for a healthier tomorrow. #HealthTech #Innovation #PatientCare #CGM

What is possible is rapidly evolving…